TipRanks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
AGN
Argenica Therapeutics Ltd
RESEARCH TOOLSreports
Want to see AU:AGN full AI Analyst Report?

Argenica Therapeutics Ltd (AGN) Income Statement

14 Followers

Argenica Therapeutics Ltd Income Statement

Last quarter (Q4 2026), Argenica Therapeutics Ltd's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was AU$2.45M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10K
Gross Profit
AU$ 0.00AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10K
Operating Expenses
AU$ 7.06MAU$ 10.90MAU$ 8.27MAU$ 6.62MAU$ 4.35M
Depreciation and Amortization
AU$ 0.00AU$ 7.68MAU$ 5.67MAU$ 4.87MAU$ 4.09M
EBITDA
AU$ -7.06MAU$ 0.00AU$ -1.90MAU$ -1.32MAU$ -257.41K
Operating Income
AU$ -7.06MAU$ -7.68MAU$ -5.67MAU$ -6.62MAU$ -4.09M
Other Income/Expenses
AU$ 1.72MAU$ 512.25KAU$ -1.90MAU$ 431.93KAU$ 1.68K
Pretax Income
AU$ -5.34MAU$ -7.17MAU$ -7.57MAU$ -6.19MAU$ -4.09M
Net Income
AU$ -1.37MAU$ -7.17MAU$ -5.48MAU$ -4.82MAU$ -4.09M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06
Diluted EPS
AU$ -0.01AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06
Weighted Average Shares Outstanding
 128.46M 127.53M 103.39M 87.58M 73.93M
Weighted Average Shares Outstanding (Diluted)
 128.46M 127.53M 103.71M 87.58M 73.93M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History